Unlock instant, AI-driven research and patent intelligence for your innovation.

Pharmaceutical composition for treating gout

A composition and drug technology, applied in the direction of drug combination, medical formula, plant raw materials, etc., can solve the problems of patients with ineffective curative effect, toxic side effects, hemorrhagic enteritis, etc., and achieve obvious therapeutic effect and good effect

Inactive Publication Date: 2017-10-10
广州智润生物制药科技有限公司
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the treatment of this disease is still based on western medicine, colchicine and allopurinol are commonly used. The above-mentioned medicines are mostly palliative medicines, which are difficult to cure, and are accompanied by obvious toxic and side effects, such as gastrointestinal discomfort, severe In severe cases, hemorrhagic enteritis and leukopenia in the blood will occur, aplastic anemia, hair loss, myopathy, liver function damage, mental depression, etc.
Previously, traditional Chinese medicines used to treat gout included Erwuwei Huaihua Pills, Linhai Jinguning and a small number of proprietary medicines, but the cure rate was not high, and the curative effect was not obvious for some patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0013] A medicinal composition for treating gout, which is composed of the following Chinese medicinal materials in proportions by weight: 10 parts of geranium seed, 15 parts of red rattan, 20 parts of chicken bone grass, 20 parts of achyranthes bidentata, and 20 parts of plantago seed.

[0014] Each component in this formula is 1 dose, decocted in water, 1 dose per day, divided into 2 doses per day.

Embodiment 2

[0016] A medicinal composition for treating gout, which is composed of the following Chinese medicinal materials in proportions by weight: 30 parts of geranium seed, 25 parts of red rattan, 40 parts of chicken bone grass, 30 parts of achyranthes bidentata, and 40 parts of plantago seed.

[0017] Each component in this formula is 1 dose, decocted in water, 1 dose per day, divided into 2 doses per day.

Embodiment 3

[0019] A medicinal composition for treating gout, which is composed of the following Chinese medicinal materials in proportions by weight: 20 parts of geranium seeds, 20 parts of red rattan, 26 parts of chicken bone grass, 24 parts of achyranthes bidentata, and 30 parts of psyllium seed.

[0020] Each component in this formula is 1 dose, decocted in water, 1 dose per day, divided into 2 doses per day.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating gout. The pharmaceutical composition is prepared from the following traditional Chinese medicines in parts by weight: 10-30 parts of muskroot-like semiaquilegia root, 15-25 parts of sargentgloryvine stem, 20-40 parts of herba abri, 20-30 parts of twotooth achyranthes root and 20-40 parts of semen plantaginis. The pharmaceutical composition for treating gout has good effects in treating gout and has obvious therapeutic effects proven by clinical tests.

Description

technical field [0001] The invention relates to a pharmaceutical composition, in particular to a pharmaceutical composition for treating gout. Background technique [0002] Gout is a crystal-associated arthropathy caused by the deposition of monosodium urate (MSU), which is directly related to hyperuricemia caused by purine metabolic disorders and / or decreased uric acid excretion, especially acute characteristic arthritis and Chronic tophi diseases mainly include acute onset arthritis, tophi formation, tophi chronic arthritis, urate nephropathy and uric acid urolithiasis. In severe cases, joint disability and renal insufficiency may occur. [0003] In recent years, the number of patients has increased significantly. At present, the treatment of this disease is still based on western medicine, colchicine and allopurinol are commonly used. The above-mentioned medicines are mostly palliative medicines, which are difficult to cure, and are accompanied by obvious toxic and side ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/71A61P19/06
CPCA61K36/71A61K36/185A61K36/21A61K36/48A61K36/486A61K36/68
Inventor 蔡哲宇
Owner 广州智润生物制药科技有限公司